ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Hans Meisner
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Massoudy, P.
Right arrow Articles by Meisner, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Massoudy, P.
Right arrow Articles by Meisner, H.

Ann Thorac Surg 1999;67:1059-1064
© 1999 The Society of Thoracic Surgeons

Original Article

Sodium nitroprusside during coronary artery bypass grafting: evidence for an antiinflammatory action

Parwis Massoudy, MDa, Stefan Zahler, PhDb, Andreas Barankay, MDc, Bernhard F. Becker, MD, PhDb, Josef A. Richter, MDc, Hans Meisner, MDa

a Departments of Department of Cardiovascular Surgery, German Heart Center Munich, Munich, Germany
b Department of Anesthesiology, German Heart Center Munich, Munich, Germany
c Department of Physiology, University of Munich, Munich, Germany

Accepted for publication October 14, 1998.

Address reprint requests to Dr Massoudy, Department of Cardiovascular Surgery, German Heart Center Munich, Lazarettstr 36, 80636 Munich, Germany
e-mail: massoudy{at}dhm.mhn.de

Background. It was the aim of the present study to investigate whether a nitric oxide donor can reduce systemic inflammation and the cardiac inflammatory response during coronary artery bypass grafting with cardiopulmonary bypass.

Methods. Patients undergoing elective coronary artery bypass grafting (n = 22) were randomly assigned to treatment with either sodium nitroprusside (0.5 µg · kg-1 · min-1) or placebo (controls), both for the first 20 minutes of reperfusion. Interleukin-6 and interleukin-8 levels, the adhesion molecules CD41 and CD62 on platelets and CD41 on monocytes and PMN (as markers for coaggregate formation), CD11b on monocytes and PMN, as well as platelet and leukocyte counts were determined in radial artery and coronary sinus blood before cardiopulmonary bypass and during reperfusion (1, 5, 10, 25, and 35 minutes).

Results. A reduction of systemic interleukin-6 levels (15.4 ± 3.5 pg/mL, 36.7 ± 5.9 pg/mL, and 46.8 ± 8.0 pg/mL versus 33.4 ± 7.7 pg/mL, 76.7 ± 13.2 pg/mL, and 106.0 ± 26.5 pg/mL, respectively, at 1, 25, and 35 minutes of reperfusion) and interleukin-8 (29.6 ± 4.5 pg/mL versus 54.0 ± 9.4, pg/mL, resp., at 35 minutes of reperfusion) resulted from treatment with sodium nitroprusside. No intracardiac production of interleukin-8 in sodium nitroprusside-treated patients (-1.1 ± 0.4 pg/mL and -2.8 ± 2.2 pg/mL, resp., for the coronary sinus–radial artery difference at 5 and 25 minutes of reperfusion) was observed, whereas cardiac production of interleukin-8 was present in controls (2.5 ± 1.5 pg/mL and 5.5 ± 2.8 pg/mL, resp.). Retention of platelet/leukocyte coaggregates occurred during coronary passage in controls (coronary sinus–radial artery difference for CD41-positive monocytes at 1 and 10 minutes of reperfusion, -16.3% ± 8.5% and -8.8% ± 2.6%, resp.). This was reduced in sodium nitroprusside-treated patients (with 5.8% ± 5.2% and 0.0% ± 3.2%). Retention of platelets in controls (ratio of coronary sinus to radial artery platelet count at 5 and 10 minutes of reperfusion, 88% ± 6% and 91% ± 5%) was compared to washout in treated patients (108% ± 6% and 113% ± 7%).

Conclusions. In patients undergoing routine coronary artery bypass grafting, administration of sodium nitroprusside during early reperfusion alleviates systemic inflammation and the cardiac inflammatory response.




This article has been cited by other articles:


Home page
 CirculationHome page
G. M. Marcus and J. E. Olgin
Preventing Atrial Fibrillation After Cardiac Surgery: A New Method Using an Old Tool
Circulation, July 29, 2008; 118(5): 467 - 468.
[Full Text] [PDF]

Home page
 CirculationHome page
R. Cavolli, K. Kaya, A. Aslan, O. Emiroglu, S. Erturk, O. Korkmaz, M. Oguz, R. Tasoz, and U. Ozyurda
Does Sodium Nitroprusside Decrease the Incidence of Atrial Fibrillation After Myocardial Revascularization?: A Pilot Study
Circulation, July 29, 2008; 118(5): 476 - 481.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
A. Boning, J. Scheewe, T. Ivers, C. Friedrich, J. Stieh, S. Freitag, and J. T. Cremer
Phosphorylcholine or heparin coating for pediatric extracorporeal circulation causes similar biologic effects in neonates and infants
J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1458 - 1465.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
D. L. Ngaage
Off-pump coronary artery bypass grafting: the myth, the logic and the science
Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 557 - 570.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
O. Cakir, A. Oruc, S. Eren, H. Buyukbayram, L. Erdinc, and N. Eren
Does sodium nitroprusside reduce lung injury under cardiopulmonary bypass?
Eur. J. Cardiothorac. Surg., June 1, 2003; 23(6): 1040 - 1045.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
P. Tassani, A. Barankay, F. Haas, S. U. Paek, M. Heilmaier, J. Hess, R. Lange, and J. A. Richter
Cardiac surgery with deep hypothermic circulatory arrest produces less systemic inflammatory response than low-flow cardiopulmonary bypass in newborns
J. Thorac. Cardiovasc. Surg., April 1, 2002; 123(4): 648 - 654.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
D. Paparella, T.M. Yau, and E. Young
Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update
Eur. J. Cardiothorac. Surg., February 1, 2002; 21(2): 232 - 244.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. Massoudy, S. Zahler, B. F. Becker, S. L. Braun, A. Barankay, and H. Meisner
Evidence for Inflammatory Responses of the Lungs During Coronary Artery Bypass Grafting With Cardiopulmonary Bypass
Chest, January 1, 2001; 119(1): 31 - 36.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
P. Massoudy, S. Zahler, P. Tassani, B. F. Becker, J. A. Richter, M. Pfauder, R. Lange, and H. Meisner
Reduction of pro-inflammatory cytokine levels and cellular adhesion in CABG procedures with separated pulmonary and systemic extracorporeal circulation without an oxygenator
Eur. J. Cardiothorac. Surg., June 1, 2000; 17(6): 729 - 736.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
P. Massoudy, S. Zahler, T. Freyholdt, R. Henze, A. Barankay, B. F. Becker, S. L. Braun, and H. Meisner
SODIUM NITROPRUSSIDE IN PATIENTS WITH COMPROMISED LEFT VENTRICULAR FUNCTION UNDERGOING CORONARY BYPASS: REDUCTION OF CARDIAC PROINFLAMMATORY SUBSTANCES
J. Thorac. Cardiovasc. Surg., March 1, 2000; 119(3): 566 - 574.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. A. Guyton, V. H. Thourani, J. D. Puskas, J. S. Shanewise, M. A. Steele, C. L. Palmer-Steele, and J. Vinten-Johansen
Perfusion-assisted direct coronary artery bypass: selective graft perfusion in off-pump cases
Ann. Thorac. Surg., January 1, 2000; 69(1): 171 - 175.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1999 by The Society of Thoracic Surgeons.